Hyaluronic Acid Herbal Extract
GET A QUOTE REQUEST MSDS
Get A Quote
List
1

Popular searches

Recommended products

Guanidine Carbonate
050-000-001 Dihydromyricetin
050-000-207 Triptolide
020-000-118 Micro Hyaluronic Acid (Micro HA), Super Active
020-000-275 Methacrylated Hyaluronic Acid (HAMA)
  • Home
  • Pharmaceuticals
  • (Discontinued) 040-000-333 Lopinavir, CAS 192725-17-0

    • SKIP TO

    (Discontinued) 040-000-333 Lopinavir, CAS 192725-17-0

    (0)
    Write a review

    About This Item

    Catalog No.
    040-000-333

    Discontinued

    Synonyms (αS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-
    Type HIV, AIDS, cell signaling
    Related products Ritonavir,  Piperaquine, Chloroquine Diphosphate, Artemisinin, Acrichin Dihydrochloride

    Quantity

    kg
    Inquiry Add to cart

    Technical Service

    Need help? Our team of experienced scientists is here for you.
    Contact us

    Description

    Lopinavir Specifications


    Product Name Lopinavir
    CAS Registry Number 192725-17-0
    Molecular Formula C37H48N4O5
    Molecular Weight 628.81 g/mol
    Purity 98 %
    Package 1kg-25kg
    Shelf life 2 years
    Functions Prevention of HIV

    Lopinavir Description


    Lopinavir is an antiretroviral drug of the class of protease inhibitors. It is used in combination with ritonavir (lopinavir/ritonavir), another protease inhibitor, in a fixed dose to fight HIV infection.

    Lopinavir is an antiretroviral protease inhibitor used in combination with ritonavir in the therapy and prevention of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS).

    lopinavir

    Lopinavir Applications


    • Lopinavir is an antiretroviral protease inhibitor used in combination with ritonavir in the therapy and prevention of human immunodeficiency virus (HIV) infection.
    • Lopinavir has been used as a ZMPSTE24 and human immunodeficiency virus protease inhibitor.

    Reference:


    1. Capparelli E, Holland D, Okamoto C, et al. (2005). "Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV". AIDS. 19 (9).

    Reviews

    5 Stars
    2
    4 Stars
    0
    3 Stars
    0
    2 Stars
    0
    1 Stars
    0
    Write a review

    Related Products

    Guanidine Carbonate
    Inquiry Add to List
    Sumatriptan Succinate
    Inquiry Add to List
    Allantoin
    Inquiry Add to List
    (R)-Amino-(4-hydroxyphenyl)acetic acid methyl ester hydrochloride
    Inquiry Add to List
    D(-)-4-Hydroxyphenylglycine
    Inquiry Add to List
    Potassium (R)-[(3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino]phenylacetate
    Inquiry Add to List

    Write a Review

    Name
    E-mail
    Rating
    Review

    Get a Quote

    Send us an inquiry now to find out more information and the latest prices, thanks!
    Product Name
    Quantity
    Name
    Email
    Phone
    Company
    Application
    Country
    United States
    • United States
    • Afghanistan
    • Aland Islands
    • Albania
    • Algeria
    • American Samoa
    • Andorra
    • Angola
    • Anguilla
    • Antarctica
    • Antigua and Barbuda
    • Argentina
    • Armenia
    • Aruba
    • Australia
    • Austria
    • Azerbaijan
    • Bahamas
    • Bahrain
    • Bangladesh
    • Barbados
    • Belarus
    • Belgium
    • Belize
    • Benin
    • Bermuda
    • Bhutan
    • Bolivia
    • Bosnia and Herzegovina
    • Botswana
    • Bouvet Island
    • Brazil
    • British Indian Ocean Territory
    • British Virgin Islands
    • Brunei
    • Bulgaria
    • Burkina Faso
    • Burundi
    • Cambodia
    • Cameroon
    • Canada
    • Cape Verde
    • Cayman Islands
    • Central African Republic
    • Chad
    • Chile
    • China
    • Christmas Island
    • Cocos (Keeling) Islands
    • Colombia
    • Comoros
    • Congo
    • Cook Islands
    • Costa Rica
    • Croatia
    • Cuba
    • Cyprus
    • Czech Republic
    • Democratic Republic of Congo
    • Denmark
    • Disputed Territory
    • Djibouti
    • Dominica
    • Dominican Republic
    • East Timor
    • Ecuador
    • Egypt
    • El Salvador
    • Equatorial Guinea
    • Eritrea
    • Estonia
    • Ethiopia
    • Falkland Islands
    • Faroe Islands
    • Federated States of Micronesia
    • Fiji
    • Finland
    • France
    • French Guyana
    • French Polynesia
    • French Southern Territories
    • Gabon
    • Gambia
    • Georgia
    • Germany
    • Ghana
    • Gibraltar
    • Greece
    • Greenland
    • Grenada
    • Guadeloupe
    • Guam
    • Guatemala
    • Guinea
    • Guinea-Bissau
    • Guyana
    • Haiti
    • Heard Island and Mcdonald Islands
    • Honduras
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Iran
    • Iraq
    • Iraq-Saudi Arabia Neutral Zone
    • Ireland
    • Israel
    • Italy
    • Ivory Coast
    • Jamaica
    • Japan
    • Jordan
    • Kazakhstan
    • Kenya
    • Kiribati
    • Kuwait
    • Kyrgyzstan
    • Laos
    • Latvia
    • Lebanon
    • Lesotho
    • Liberia
    • Libya
    • Liechtenstein
    • Lithuania
    • Luxembourg
    • Macau
    • Macedonia
    • Madagascar
    • Malawi
    • Malaysia
    • Maldives
    • Mali
    • Malta
    • Marshall Islands
    • Martinique
    • Mauritania
    • Mauritius
    • Mayotte
    • Mexico
    • Moldova
    • Monaco
    • Mongolia
    • Montenegro
    • Montserrat
    • Morocco
    • Mozambique
    • Myanmar
    • Namibia
    • Nauru
    • Nepal
    • Netherlands Antilles
    • Netherlands
    • New Caledonia
    • New Zealand
    • Nicaragua
    • Niger
    • Nigeria
    • Niue
    • Norfolk Island
    • North Korea
    • Northern Mariana Islands
    • Norway
    • Oman
    • Pakistan
    • Palau
    • Palestinian Territories
    • Panama
    • Papua New Guinea
    • Paraguay
    • Peru
    • Philippines
    • Pitcairn Islands
    • Poland
    • Portugal
    • Puerto Rico
    • Qatar
    • Reunion
    • Romania
    • Russia
    • Rwanda
    • Saint Helena and Dependencies
    • Saint Kitts and Nevis
    • Saint Lucia
    • Saint Pierre and Miquelon
    • Saint Vincent and the Grenadines
    • Samoa
    • San Marino
    • Sao Tome and Principe
    • Saudi Arabia
    • Senegal
    • Serbia
    • Seychelles
    • Sierra Leone
    • Singapore
    • Slovakia
    • Slovenia
    • Solomon Islands
    • Somalia
    • South Africa
    • South Georgia and South Sandwich Islands
    • South Korea
    • Spain
    • Spratly Islands
    • Sri Lanka
    • Sudan
    • Suriname
    • Svalbard and Jan Mayen
    • Swaziland
    • Sweden
    • Switzerland
    • Syria
    • Taiwan
    • Tajikistan
    • Tanzania
    • Thailand
    • Togo
    • Tokelau
    • Tonga
    • Trinidad and Tobago
    • Tunisia
    • Turkey
    • Turkmenistan
    • Turks And Caicos Islands
    • Tuvalu
    • US Virgin Islands
    • Uganda
    • Ukraine
    • United Arab Emirates
    • United Kingdom
    • United States
    • United States Minor Outlying Islands
    • Uruguay
    • Uzbekistan
    • Vanuatu
    • Vatican City
    • Venezuela
    • Vietnam
    • Wallis and Futuna
    • Western Sahara
    • Yemen
    • Zambia
    • Zimbabwe
    Comments
    I would like to join the mailing list to receive updates from Stanford Chemicals.
    Check Code